These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Network medicine: finding the links to personalized therapy. Chen JY; Piquette-Miller M; Smith BP Clin Pharmacol Ther; 2013 Dec; 94(6):613-6. PubMed ID: 24241633 [TBL] [Abstract][Full Text] [Related]
7. Drugs, diabetes and pharmacogenomics: the road to personalized therapy. Watanabe RM Pharmacogenomics; 2011 May; 12(5):699-701. PubMed ID: 21619432 [No Abstract] [Full Text] [Related]
8. Introduction. Personalizing patient care with precision medicine. Wujcik D; Knoop T Semin Oncol Nurs; 2014 May; 30(2):81-3. PubMed ID: 24794081 [No Abstract] [Full Text] [Related]
9. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics. Parkinson DR; Johnson BE; Sledge GW Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894 [TBL] [Abstract][Full Text] [Related]
10. [Personalized therapy]. Hallek M; Wolf J Internist (Berl); 2013 Feb; 54(2):145-6. PubMed ID: 23371256 [No Abstract] [Full Text] [Related]
11. Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician. Neely M; Jelliffe R J Clin Pharmacol; 2010 Jul; 50(7):842-7. PubMed ID: 20154293 [No Abstract] [Full Text] [Related]
12. Proteomic advances hold promise for precision medicine. Smith AD Am J Manag Care; 2014 Mar; 20(5 Spec No.):E14. PubMed ID: 25618628 [No Abstract] [Full Text] [Related]
13. Prospects of personalized medicine in cardiovascular diseases. Lenfant C Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711 [TBL] [Abstract][Full Text] [Related]
14. [Targeted therapy of a cancer patient is multiprofessional collaboration]. Ristimäki A; Kytölä S; Haglund C; Bono P Duodecim; 2013; 129(10):1071-9. PubMed ID: 23767137 [TBL] [Abstract][Full Text] [Related]
15. Individualization of drug therapy: history, present state, and opportunities for the future. Lesko LJ; Schmidt S Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891 [TBL] [Abstract][Full Text] [Related]
17. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?]. Greillier L; Barlesi F Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212 [No Abstract] [Full Text] [Related]